|
May 19
|
1 Safe-and-Steady Stock on Our Buy List and 2 to Ignore
|
|
May 2
|
United Therapeutics First Quarter 2025 Earnings: Beats Expectations
|
|
May 1
|
UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales
|
|
May 1
|
United Therapeutics Corp (UTHR) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
May 1
|
1 Value Stock Worth Investigating and 2 to Brush Off
|
|
May 1
|
Q1 2025 United Therapeutics Corp Earnings Call
|
|
Apr 30
|
United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
Apr 30
|
United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates
|
|
Apr 30
|
United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1
|
|
Apr 30
|
United Therapeutics: Q1 Earnings Snapshot
|
|
Apr 30
|
United Therapeutics Corporation Reports First Quarter 2025 Financial Results
|
|
Apr 29
|
United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Apr 28
|
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
|
|
Feb 14
|
United Therapeutics (UTHR): Buy, Sell, or Hold Post Q3 Earnings?
|
|
Feb 13
|
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
|
|
Feb 13
|
Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?
|
|
Feb 12
|
United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now
|
|
Jan 21
|
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress
|
|
Jan 20
|
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|